mannose has been researched along with chitosan in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.85) | 18.2507 |
| 2000's | 7 (12.96) | 29.6817 |
| 2010's | 28 (51.85) | 24.3611 |
| 2020's | 18 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, P; Kuramoto, Y; Lim, BO; Nonaka, M; Sugano, M; Yamada, K | 1 |
| Fukuyama, S; Hayashi, S; Hirose, J; Kinoshita, Y; Takasaki, Y; Yokoi, H | 1 |
| Eriguchi, M; Hashimoto, M; Morimoto, M; Saimoto, H; Sato, T; Shigemasa, Y; Yanagie, H | 1 |
| Cho, CS; Cho, MH; Jin, H; Kim, HW; Kim, TH | 1 |
| Chen, Y; Jin, Y; Kong, W; Liu, B; Liu, J; Shan, Y; Shen, J; Wang, X; Wu, Y; Yu, X; Zha, X; Zhang, X; Zhou, X | 2 |
| Akaike, T; Cho, CS; Jiang, HL; Kang, ML; Kang, SG; Quan, JS; Yoo, HS | 1 |
| Arote, R; Cho, CS; Cho, MH; Choi, YJ; Jere, D; Jiang, HL; Kim, YK; Nah, JW; Quan, JS; Yu, JH | 1 |
| Du, M; Jiao, Y; Luo, J; Yao, W; Zong, L | 1 |
| Cao, QR; Chen, D; Chen, L; Cui, J; Zhu, L | 1 |
| Brayden, DJ; Coco, R; Jérôme, C; Plapied, L; Pourcelle, V; Préat, V; Schneider, YJ | 1 |
| Cheng, J; Gabrielson, NP; Kim, KH; Song, Z; Yin, L; Zheng, N | 1 |
| Du, M; Luo, J; Peng, Y; Yao, W; Zong, L | 1 |
| Chaubey, P; Mishra, B | 1 |
| Bhanuprakash, V; Chandra Sekar, S; Edao, BM; Ganesh, K; Hajam, IA; Kishore, S; Nanda, RK; Rajangam, M; Ramya, K | 1 |
| Chaubey, P; Mishra, B; Patel, RR | 1 |
| Asthana, A; Asthana, GS; Kohli, DV; Vyas, SP | 1 |
| Cho, CS; Cui, PF; Jiang, HL; Xie, RL | 1 |
| Cui, Z; Feng, X; Gu, J; Han, D; Han, W; Lei, L; Sun, C; Sun, X; Tong, C; Zhang, M | 1 |
| He, C; Song, Y; Tang, C; Yin, C; Yin, L | 1 |
| Chu, S; Tang, C; Yin, C | 1 |
| Layek, B; Lipp, L; Singh, J | 1 |
| Han, Z; Lu, H; Zeng, Y; Zhang, L | 1 |
| Peng, Y; Wang, B; Yao, W; Zong, L | 1 |
| Donno, R; Gennari, A; Kimber, I; Pelliccia, M; Tirelli, N | 1 |
| Akhtar, S; Edagwa, BJ; Gendelman, HE; McMillan, J; Qureshi, NA; Raza, A; Shahnaz, G; Yasinzai, M | 1 |
| Kaira, GS; Kapoor, M; Panwar, D | 1 |
| Li, M; Wu, M; Xiong, S; Xu, W; Yue, Y; Zhao, H | 1 |
| Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Ajdary, S; Amani, A; Doroud, D; Dounighi, NM; Khoobi, M; Mehrabi, M; Pilehvar-Soltanahmadi, Y; Rezayat Sorkhabadi, SM | 1 |
| Chaubey, P; Chaurasia, S; Mishra, B; Monteiro, M; Mudavath, SL; Patel, RR; Sundar, S; Suvarna, V | 1 |
| Akhtar, S; Gendelman, HE; Nadhman, A; Rehman, AU; Saljoughian, N; Sarwar, HS; Satoskar, AR; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Chen, Y; Wang, B; Xu, B; Xu, Y; Zhang, W; Zong, L | 1 |
| Biton, A; Coya, JM; Danckaert, A; De la Fuente, JM; De Matteis, L; Dillies, MA; Gicquel, B; Giraud-Gatineau, A; Serrano-Sevilla, I; Tailleux, L | 1 |
| Hou, T; Wang, T; Yin, X; Zhang, J; Zhang, N | 1 |
| Caillol, S; Chapelle, C; David, G; Desroches le Foll, M; Durand, G; Negrell, C; Trombotto, S | 1 |
| He, C; Liu, Y; Song, Y; Tang, C; Xu, L; Yin, C; Yue, H | 1 |
| Azizi, M; Bouzari, S; Fasihi-Ramandi, M; Sadeghi, Z | 1 |
| Babii, O; Chen, L; Liu, G; Martinez, EC; van Drunen Littel-van den Hurk, S; Wang, Z | 1 |
| Agnihotri, VV; Pardeshi, CV; Pardeshi, SR; Patil, KY; Surana, SJ | 1 |
| Dhakal, S; Feliciano-Ruiz, N; Han, Y; Hanson, J; Krakowka, S; Patil, V; Ramesh, A; Renu, S; Renukaradhya, GJ; Schrock, J | 1 |
| He, Y; Huang, Y; Jiang, O; Li, F; Li, Y; Liu, Y; Ma, C; Wan, W; Wen, Q; Xu, Q; Yang, H; Yu, J; Zeng, Z | 1 |
| Chaubey, P; Fernandes, T; Kaur, P; Narayanan, S; Prabhu, P; Sawarkar, SP; Vk, R | 1 |
| Hu, G; Jin, Z; Zhao, K | 1 |
| Chang, Y; Chen, R; Kang, S; Ma, Y; Qiao, H; Sun, W; Zhang, Y; Zhao, Y | 1 |
| Duan, HX; Jiang, FY; Xia, JY; Zhao, Z; Zhou, GQ; Zhu, B | 1 |
| Guo, S; Wang, GX; Zhang, C; Zhang, PQ; Zhao, Z; Zhu, B | 1 |
| Abdalla, M; Chi, Z; Hamouda, HI; Liu, C; Shabana, S; Sharaf, M | 1 |
| Bedhiafi, T; Billa, N; Dermime, S; Hijji, Y; Idoudi, S; Korashy, HM; Merhi, M; Uddin, S | 1 |
| Abdalla, M; Ahmad, R; Arif, M; Eltayb, WA; Liu, CG; Muhammad, J; Sharaf, M | 1 |
| Damei, FA; Kalunke, RM; Lee, HC; Lin, YH; Ma, LS; Tsai, WL; Xu, MY | 1 |
| Hang, F; Hou, L; Hu, N; Li, K; Xie, C; Yu, J | 1 |
| Barbosa, AI; Lima, SAC; Reis, S; Serrasqueiro, F | 1 |
| Babayeva, M; Fomin, G; Petrovsky, N; Renu, S; Renukaradhya, GJ; Solomadin, M; Tabynov, K; Turebekov, N; Yadagiri, G; Yerubayev, T | 1 |
1 review(s) available for mannose and chitosan
| Article | Year |
|---|---|
Chemical modification of chitosan for efficient gene therapy.
Topics: Amino Acids; Animals; Blood-Brain Barrier; Chitosan; Folic Acid; Galactose; Genetic Therapy; Genetic Vectors; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Ligands; Magnetics; Mannose; Sulfhydryl Compounds; Transfection | 2014 |
53 other study(ies) available for mannose and chitosan
| Article | Year |
|---|---|
Dietary fibers modulate indices of intestinal immune function in rats.
Topics: Animals; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Cellulose; Chitin; Chitosan; Cytokines; Dietary Fiber; Flow Cytometry; Growth; Immune System; Immunoglobulins; Interferon-gamma; Intestinal Mucosa; Intestines; Lymphocytes; Male; Mannose; Pectins; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1997 |
Continuous isomerization of D-fructose to D-mannose by immobilized Agrobacterium radiobacter cells.
Topics: Albumins; Aldose-Ketose Isomerases; Cells, Immobilized; Chitin; Chitosan; Enzyme Activation; Enzyme Stability; Enzymes, Immobilized; Fructose; Glutaral; Isomerism; Mannose; Quality Control; Rhizobium; Temperature | 2003 |
Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages.
Topics: Animals; Cells, Cultured; Chitosan; DNA; Gene Transfer Techniques; Genetic Vectors; Lectins, C-Type; Macrophages, Peritoneal; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Microscopy, Confocal; Plasmids; Receptors, Cell Surface; Transfection | 2006 |
Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells.
Topics: Animals; Apoptosis; Carcinoma; Cell Cycle; Chitosan; Dendritic Cells; Gene Transfer Techniques; Genetic Therapy; Immunotherapy; Interleukin-12; Male; Mannose; Mice; Mice, Inbred BALB C; Nanostructures; Neovascularization, Pathologic | 2006 |
Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine.
Topics: Animals; Antibody Formation; Cell Line; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Female; Hepatitis B Vaccines; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Polyethyleneimine; T-Lymphocytes, Cytotoxic; Vaccines, DNA | 2007 |
Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly.
Topics: Animals; Biocompatible Materials; Chitosan; Chlorocebus aethiops; COS Cells; Drug Carriers; Female; Immunity, Innate; Macromolecular Substances; Mannose; Materials Testing; Mice; Mice, Inbred BALB C; Vaccines, DNA | 2007 |
The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization.
Topics: Administration, Intranasal; Animals; Bacterial Toxins; Cells, Cultured; Chemotherapy, Adjuvant; Chitosan; Drug Carriers; Drug Delivery Systems; Feasibility Studies; Lectins, C-Type; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Microspheres; Receptors, Cell Surface; Transglutaminases; Vaccination; Virulence Factors, Bordetella | 2008 |
Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.
Topics: Animals; Cell Line; Chitosan; Gene Targeting; Gene Transfer Techniques; Genetic Vectors; HeLa Cells; Humans; Lectins, C-Type; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Molecular Weight; Polyethyleneimine; Receptors, Cell Surface; Toxicity Tests; Transfection | 2009 |
Practical synthesis and characterization of mannose-modified chitosan.
Topics: Cell Survival; Chemistry Techniques, Synthetic; Chitosan; Hep G2 Cells; Humans; Mannose; Spectrum Analysis; Temperature | 2012 |
Preparation and evaluation of mannose receptor mediated macrophage targeting delivery system.
Topics: Animals; Cell Line; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Flow Cytometry; Kinetics; Lactic Acid; Lectins, C-Type; Macrophages; Magnetic Resonance Spectroscopy; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Microscopy, Confocal; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Receptors, Cell Surface; Solubility; Spectrometry, Fluorescence; Technology, Pharmaceutical | 2011 |
Drug delivery to inflamed colon by nanoparticles: comparison of different strategies.
Topics: Animals; Caco-2 Cells; Chitosan; Colitis; Cytokines; Dextran Sulfate; Drug Carriers; Ethylene Oxide; Female; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Lactic Acid; Lactones; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Ovalbumin; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymethacrylic Acids | 2013 |
Non-viral gene delivery via membrane-penetrating, mannose-targeting supramolecular self-assembled nanocomplexes.
Topics: Animals; Cell Membrane; Chitosan; DNA; Drug Carriers; Drug Design; Hep G2 Cells; Humans; Luciferases; Mannose; Mice; Nanostructures; Plasmids; Polymers; Transfection | 2013 |
Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
Topics: Administration, Intranasal; Animals; Blotting, Western; Cell Line; Chitosan; Enzyme-Linked Immunosorbent Assay; Immunotherapy; Male; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Nasal Mucosa; Prostatic Neoplasms; Vaccines | 2013 |
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin | 2014 |
Immunological evaluation of mannosylated chitosan nanoparticles based foot and mouth disease virus DNA vaccine, pVAC FMDV VP1-OmpA in guinea pigs.
Topics: Animals; Antibodies, Viral; Cell Line; Chitosan; Cricetinae; Enzyme-Linked Immunosorbent Assay; Foot-and-Mouth Disease; Guinea Pigs; Immunity, Cellular; Mannose; Nanoparticles; Vaccines, DNA | 2014 |
Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
Topics: Animals; Biological Transport; Chemistry, Pharmaceutical; Chitosan; Curcumin; Drug Carriers; Drug Stability; Hydrogen-Ion Concentration; Leishmaniasis, Visceral; Male; Mannose; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Nanoparticles; Rats; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2014 |
Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting.
Topics: Animals; Cell Line; Cell Survival; Chitosan; Deoxyribonuclease I; Drug Carriers; Gene Transfer Techniques; HeLa Cells; Humans; Macrophages; Mannose; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Molecular Weight; Nanoparticles; Oligonucleotides, Antisense; Particle Size; Solubility; Tumor Necrosis Factor-alpha; Water | 2014 |
Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
Topics: Administration, Intranasal; Animals; Antibodies, Bacterial; Antibody Formation; Bacterial Proteins; Base Sequence; Cell Line; Chitosan; Female; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Interferon-gamma; Interleukin-4; Lipoproteins; Macrophages; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas Vaccines; Recombinant Proteins; T-Lymphocytes | 2015 |
Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Chitosan; Cysteine; Drug Delivery Systems; Endocytosis; Gene Silencing; Inflammation; Intestines; Liver; Macrophages; Male; Mannose; Membrane Microdomains; Nanoparticles; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2015 |
Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
Topics: Administration, Oral; Animals; Cell Line; Chitosan; Cysteine; Drug Carriers; Inflammation; Ligands; Liver; Macrophages, Peritoneal; Male; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polymers; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2015 |
APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine.
Topics: Administration, Cutaneous; Animals; Antigen-Presenting Cells; Biomarkers; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Female; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Immunity, Cellular; Immunity, Humoral; Immunization; Lymphocyte Activation; Mannose; Mice; Mice, Inbred BALB C; Micelles; Phenylalanine; RAW 264.7 Cells; T-Lymphocytes, Helper-Inducer; Transfection; Vaccines, DNA | 2015 |
Determination of the degree of acetylation and the distribution of acetyl groups in chitosan by HPLC analysis of nitrous acid degraded and PMP labeled products.
Topics: Acetylation; Antipyrine; Chitosan; Chromatography, High Pressure Liquid; Edaravone; Glucosamine; Mannose; Nitrous Acid; Oligosaccharides; Staining and Labeling | 2015 |
Mannosylated Chitosan Nanoparticles Based Macrophage-Targeting Gene Delivery System Enhanced Cellular Uptake and Improved Transfection Efficiency.
Topics: Animals; Cell Line; Chitosan; Gastrin-Releasing Peptide; Gene Transfer Techniques; Humans; Intracellular Space; Luciferases; Macrophages; Mannose; Mice; Nanoparticles; Plasmids; Transfection | 2015 |
Mannosylation Allows for Synergic (CD44/C-Type Lectin) Uptake of Hyaluronic Acid Nanoparticles in Dendritic Cells, but Only upon Correct Ligand Presentation.
Topics: Animals; Cell Line; Chitosan; Colloids; Dendritic Cells; Endocytosis; Flow Cytometry; Hyaluronan Receptors; Hyaluronic Acid; Lectins, C-Type; Ligands; Mannose; Mice; Molecular Weight; Nanoparticles; Proton Magnetic Resonance Spectroscopy; Reproducibility of Results; Time Factors | 2016 |
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Mice; Nanoparticles | 2017 |
Cross-linked enzyme aggregates (CLEAs) and magnetic nanocomposite grafted CLEAs of GH26 endo-β-1,4-mannanase: Improved activity, stability and reusability.
Topics: Chitosan; Enzyme Stability; Enzymes, Immobilized; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Magnets; Mannose; Mannosidases; Nanocomposites; Oligosaccharides; Protein Aggregates; Temperature | 2017 |
Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
Topics: Administration, Intranasal; Animals; BCG Vaccine; Bronchoalveolar Lavage Fluid; Chitosan; Cytokines; Disease Models, Animal; Epitopes, T-Lymphocyte; Female; Immunity, Cellular; Immunoglobulin A; Mannose; Mice; Mice, Inbred C57BL; Mycobacterium bovis; Mycobacterium tuberculosis; Nanoparticles; Pulmonary Alveoli; Tuberculosis Vaccines; Tuberculosis, Pulmonary; Vaccination; Vaccines, DNA | 2017 |
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties | 2018 |
Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.
Topics: Adjuvants, Immunologic; Animals; Chemical Phenomena; Chitosan; Drug Carriers; Drug Liberation; Drug Stability; Guinea Pigs; HEK293 Cells; Hepatitis B Surface Antigens; Humans; Mannose; Mice; Nanoparticles; Temperature | 2018 |
Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani.
Topics: Cell Line; Chitosan; Curcumin; Drug Carriers; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mannose; Nanoparticles | 2018 |
Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis.
Topics: Adhesiveness; Administration, Oral; Amphotericin B; Animals; Biological Availability; Cell Membrane; Chitosan; Drug Carriers; Drug Compounding; Immunomodulation; Leishmaniasis, Visceral; Mannose; Mice; Nanoparticles; Nitric Oxide; Particle Size; Permeability; Safety; Tissue Distribution | 2018 |
Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
Topics: Administration, Oral; Animals; Antigen-Presenting Cells; Cattle; Chitosan; Drug Carriers; Drug Liberation; Female; Gastric Acid; Hydrogen-Ion Concentration; Immunization; Mannose; Mice; Nanoparticles; Peyer's Patches; Polymethacrylic Acids; Serum Albumin, Bovine; Stomach Neoplasms; Subretinal Fluid; Vaccines | 2018 |
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection.
Topics: Bacterial Infections; Cells, Cultured; Chitosan; Drug Carriers; Drug Delivery Systems; Host-Pathogen Interactions; Humans; Immunity, Innate; Macrophages; Mannose; Metabolic Networks and Pathways; Mycobacterium tuberculosis; Nanoparticles; Phagocytosis; Transcriptome | 2019 |
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Topics: Animals; Benzamides; Carcinoma, Hepatocellular; Cell Survival; Chitosan; Drug Carriers; Humans; Immunotherapy; Liver Neoplasms; Macrophages; Mannose; Mice; Microscopy, Confocal; Nanoparticles; Protein Kinase Inhibitors; RAW 264.7 Cells; Sorafenib; Tissue Distribution | 2019 |
Water-Soluble 2,5-Anhydro-d-mannofuranose Chain End Chitosan Oligomers of a Very Low Molecular Weight: Synthesis and Characterization.
Topics: Chitosan; Mannose; Molecular Weight; Oligosaccharides; Solubility; Water | 2019 |
siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
Topics: Administration, Oral; Animals; Chitosan; Colitis, Ulcerative; Cysteine; Inflammation; Kinetics; Liver; Macrophages; Male; Mannose; Mice; Mice, Inbred C57BL; Nanoparticles; Polymers; RAW 264.7 Cells; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2020 |
Mannosylated chitosan nanoparticles loaded with FliC antigen as a novel vaccine candidate against Brucella melitensis and Brucella abortus infection.
Topics: Animals; Antigens, Bacterial; Antineoplastic Combined Chemotherapy Protocols; Brucella abortus; Brucella melitensis; Brucella Vaccine; Brucellosis; Chitosan; Cisplatin; Female; Ifosfamide; Mannose; Mice, Inbred BALB C; Mitomycin; Nanoparticles | 2020 |
Low molecular weight chitosan nanoparticles for CpG oligodeoxynucleotides delivery: Impact of molecular weight, degree of deacetylation, and mannosylation on intracellular uptake and cytokine induction.
Topics: Acetates; Animals; Chitosan; CpG Islands; Cytokines; Drug Liberation; Mannose; Mice; Molecular Weight; Nanoparticles; Oligodeoxyribonucleotides; RAW 264.7 Cells; Static Electricity | 2020 |
Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline.
Topics: Animals; Chitosan; Drug Carriers; Lung Diseases; Male; Mannose; Nanoparticles; Rats; Rats, Wistar; Theophylline | 2020 |
Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs.
Topics: Animals; Antibodies, Viral; Cells, Cultured; Chitosan; Dogs; Female; Immunity; Influenza Vaccines; Madin Darby Canine Kidney Cells; Mannose; Nanoparticles; Orthomyxoviridae Infections; Pregnancy; Swine; Swine Diseases; Vaccination; Vaccines, Inactivated | 2021 |
Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages.
Topics: Animals; Cell Survival; Chemistry, Pharmaceutical; Chitosan; DNA, Complementary; Dose-Response Relationship, Drug; Drug Carriers; Fibroblasts; Humans; Imidazoles; Macrophages; Male; Mannose; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Surface Properties; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; U937 Cells; Xenograft Model Antitumor Assays | 2021 |
Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis.
Topics: Chitosan; Drug Carriers; Humans; Mannose; Nanoparticles; Particle Size; Rifampin; Tuberculosis, Osteoarticular | 2021 |
Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery.
Topics: Acetylcysteine; Administration, Mucosal; Chemical Phenomena; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Macrophages; Mannose; Mucins; Nanoparticles; Particle Size | 2022 |
Mucosal immunity of mannose-modified chitosan microspheres loaded with the nontyepable Haemophilus influenzae outer membrane protein P6 in BALB/c mice.
Topics: Animals; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Chitosan; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Immunity, Mucosal; Mannose; Mice; Mice, Inbred BALB C; Microspheres; Nasal Mucosa | 2022 |
Protective immunity against spring viremia of carp virus by mannose modified chitosan loaded DNA vaccine.
Topics: Animals; Carps; Chitosan; Fish Diseases; Mannose; Rhabdoviridae; Vaccines, DNA; Viral Vaccines; Viremia | 2022 |
Dual-Targeting Polymer Nanoparticles Efficiently Deliver DNA Vaccine and Induce Robust Prophylactic Immunity against Spring Viremia of Carp Virus Infection.
Topics: Animals; Antibodies, Neutralizing; Carps; Chitosan; Fish Diseases; Immunoglobulin M; Mannose; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rhabdoviridae Infections; Vaccines, DNA; Viremia | 2022 |
Multifunctional nanoparticles based on marine polysaccharides for apremilast delivery to inflammatory macrophages: Preparation, targeting ability, and uptake mechanism.
Topics: Caco-2 Cells; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Macrophages; Mannose; Multifunctional Nanoparticles; Nanoparticles; Polysaccharides | 2022 |
A novel approach of encapsulating curcumin and succinylated derivative in mannosylated-chitosan nanoparticles.
Topics: Chitosan; Curcumin; Drug Carriers; Humans; Mannose; Nanoparticles; Neoplasms; Particle Size; Succinic Anhydrides | 2022 |
Antibacterial and antibiofilm activity of mannose-modified chitosan/PMLA nanoparticles against multidrug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Chitosan; Helicobacter Infections; Helicobacter pylori; Humans; Mannose; Molecular Docking Simulation; Nanoparticles | 2022 |
Maize Antifungal Protein AFP1 Elevates Fungal Chitin Levels by Targeting Chitin Deacetylases and Other Glycoproteins.
Topics: Antifungal Agents; Cell Wall; Chitin; Chitosan; Fungal Proteins; Glycoproteins; Mannose; Membrane Glycoproteins; Zea mays | 2023 |
Effect of deacetylation of chitosan on the physicochemical, antioxidant and antibacterial properties activities of chitosan-mannose derivatives.
Topics: Anti-Bacterial Agents; Antioxidants; Chitosan; Mannose; Spectroscopy, Fourier Transform Infrared; Water | 2023 |
Targeting the Mannose Receptor with Functionalized Fucoidan/Chitosan Nanoparticles Triggers the Classical Activation of Macrophages.
Topics: Chitosan; Macrophages; Mannose; Mannose Receptor; Nanoparticles | 2023 |
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Neutralizing; Antibodies, Viral; Chitosan; COVID-19; COVID-19 Vaccines; Cricetinae; Mannose; Mesocricetus; Mice; Mice, Inbred BALB C; Nanoparticles; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Vaccines | 2023 |